Investigation of the Ototoxic Effect of Pembrolizumab Using a Rat Model.

Kuzucu, Ihsan; Baklaci, Deniz; Guler, Ismail; Uçaryilmaz, Esra Özhamam; Kum, Rauf Oguzhan; Özcan, Müge

Kuzucu, Ihsan; Baklaci, Deniz; Guler, Ismail; Uçaryilmaz, Esra Özhamam; Kum, Rauf Oguzhan; Özcan, Müge.

Afiliación

Kuzucu I; Otolaryngology, Aksaray University, Faculty of Medicine, Aksaray, TUR.
Baklaci D; Otorhinolaryngology, Kahramankazan State Hospital, Ankara, TUR.
Guler I; Otolaryngology, Medipol University School of Medicine, Ankara, TUR.
Uçaryilmaz EÖ; Pathology, Ministry of Health Ankara City Hospital, Department of Pathology, Ankara, TUR.
Kum RO; Otolaryngology, Ministry of Health Ankara City Hospital, Department of Otolatyngology, Ankara, TUR.
Özcan M; Otolaryngology, Ministry of Health Ankara City Hospital, Department of Otolatyngology, Ankara, TUR.

Cureus ; 11(11): e6057, 2019 Nov 02.

Article en En | MEDLINE | ID: mdl-31827988

Palabras clave

ototoxicity; pembrolizumab; programmed cell death protein-1; rat

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cureus Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google